Mai Kadi

Mai Kadi

Auto-generated profile, based on publicly available information

Mai Kadi

Univ Virginia, Sch Med, POB 801075, Charlottesville, VA 22902 USA

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 June 2021 in Cureus
Verified
Journal Article
Open access
NTNora H. Trabulsi
Nora H. Trabulsi
ASAlaa A Shabkah
Alaa A Shabkah
RUReem Ujaimi
Reem Ujaimi
OIOmar Iskanderani
Omar Iskanderani
MKMai S. Kadi
Mai S. Kadi
ASAli A Samkari
Ali A Samkari
Breast cancer (BC) is the most common cancer in the Kingdom of Saudi Arabia (KSA) and the second leading cause of cancer-related mortality. About 40% of BC in KSA is locally advanced BC (LABC), which has been associated with poorer survival compared with early diagnosed BC. To review the presentation and outcomes of LABC, including the characteristics of the disease, different treatment modalities, overall survival (OS), disease-free survival (DFS), and local recurrence in relation to different radiotherapy (RT) techniques. We retrospectively reviewed the medical records of 153 female patients with pathologically proven LABC diagnosed at King Abdulaziz University Hospital, Jeddah, KSA, between 2009 and 2017. We obtained data on patient demographics, stage of cancer at diagnosis, tumor characteristics (subtype and receptor status), type of surgery, systemic treatments received (hormonal, targeted therapy, and chemotherapy), RT variables, and recurrence and death dates. Data were analyzed to assess OS and DFS by using Kaplan-Meier analyses and the log-rank test. Univariate and multivariate Cox proportional hazard regression analyses were used to explore and identify factors associated with survival. The median survival time in the study population was 9.16 years. Older age (65+ years) was associated with worse OS and DFS than was younger age (<65 years) (hazard ratio (HR) 3.20, 95% CI 1.48-6.90, P = 0.003 and HR 2.21, 95% CI 1.12-4.36, P = 0.022, respectively). Regarding the type of surgery, having a mastectomy was associated with worse OS and DFS than was having a lumpectomy (HR 2.44, 95% CI 0.97-6.12, P = 0.05 and HR 2.41, 95% CI 1.13-5.14, P = 0.023, respectively). Positive estrogen and progesterone receptor status was associated with better OS and DFS than was a negative estrogen or progesterone receptor status (HR 0.13, 95% CI 0.05-0.30, P < 0.001 and HR 0.21, 95% CI 0.11-0.41, P < 0.001, respectively). Patients who received RT had a lower risk of recurrence than did those who did not receive RT (P = 0.011). Moreover, three-dimensional conformal RT was associated with lower local recurrence than intensity-modulated RT or volumetric-modulated arc therapy (P = 0.003). Multiple factors can affect the OS and DFS in LABC. Younger patients, having hormone-positive disease, and undergoing lumpectomy were associated with better outcomes. Adjuvant RT may improve local control and the use of three-dimensional conformal RT was superior for local control. Prospective studies with larger sample sizes are needed to further highlight these findings and to assess the role of chemotherapy and targeted therapy in patients with LABC.

15 November 2021 in Journal of Pharmaceutical Research International
Verified
Journal Article
Open access
PDF file
RARahaf Nabil Alaaddin
Rahaf Nabil Alaaddin
NINahla Khamis Ibrahim
Nahla Khamis Ibrahim
MKMai Kadi
Mai Kadi
Background: Leadership is a vital attribute for the predictive quality of care in healthcare organizations. Leadership has an effective role in improving clinical outcomes, pharmacy practice, and patient satisfaction. However, limited studies have been done on leadership among pharmacy students in Makkah. The current study was conducted to describe the leadership skills and their associated factors among pharmacy students at Umm Al-Qura University (UQU), Makkah. Methods: An analytical cross-sectional study was done. A multi-stage stratified random sampling technique was used. Stratification considered the gender, educational program (Pharm-D or B-Pharm), and educational year. A standardized data collection sheet was used and asked about personal, sociodemographic data, the Authentic Leadership Questionnaire (ALQ), Schutte Self-Report Emotional Intelligence (SSREI) scale, Depression Anxiety and Stress Scale (DASS). Descriptive statistics were done. Inferential statistics were done using the Student’s t-test and ANOVA for comparing between means. Pearson’s product-moment correlations were also calculated. Multilinear regression models were constructed to determine the leadership predictors. Results: A total of 400 pharmacy students participated in the study. Pharmacy students had high overall leadership competencies; the mean overall score of ALQ was 57.98 ±7.47. The highest leadership category score was for the internalized moral skills (15.04 ±2.43). Multiple linear regression analyses revealed that the predictors of the overall authentic leadership skills were high EI score (B= 0.4; 95% CI: 0.37-0.44) and absence of depression (B= -1.48; 95% CI: - 2.51, - 0.46). Depression was also negatively associated with self-awareness, internalized moral domains. Marital status, physical activity and father education also associated with different leadership domains. Conclusion: The predictors of the total authentic leadership skills were the overall EI domain score and absence of depression. Training on both leadership skills, and emotional intelligence is essential. Management of depression and encouraging physical activities are needed for better leadership skills. These efforts may result in the development of highly qualified health care personnel.

19 August 2024 in JMIR Research Protocols
Verified
Journal Article
Open access
KSKelly M Shaffer
Kelly M Shaffer
JRJennifer Barsky Reese
Jennifer Barsky Reese
EDEmily V Dressler
Emily V Dressler
JGJillian V Glazer
Jillian V Glazer
WCWendy Cohn
Wendy Cohn
LRLee M Ritterband
Lee M Ritterband
Background: Although most survivors of breast cancer report substantial sexual concerns following treatment, few receive support for these concerns. Delivering sexual health care to survivors of breast cancer via the internet could overcome many of the barriers to in-person treatment. Even when delivered remotely, survivor time constraints remain a leading barrier to sexual health intervention uptake. Objective: Guided by the multiphase optimization strategy methodological framework, the primary objective of this study is to identify the most efficient internet-delivered sexual health intervention package that is expected to provide survivors of breast cancer the greatest benefit with the fewest (and least-intensive) intervention components. This study aims to determine how intervention components work (mediators) and for whom they work best (moderators). Methods: Partnered, posttreatment adult female survivors of breast cancer (N=320) experiencing at least 1 bothersome sexual symptom (ie, pain with sex, vaginal dryness, low sexual desire, and difficulty with orgasm) related to their breast cancer treatment will be enrolled. Clinic-based recruitment will be conducted via the Wake Forest National Cancer Institute Community Oncology Research Program (NCORP) Research Base. Participants will be randomly assigned to 1 of 16 combinations of four intervention components with two levels each in this factorial trial: (1) psychoeducation about cancer-related sexual morbidity (receive either enhanced vs standard versions); (2) communication skills training for discussing concerns with health care providers (received vs not received); (3) communication skills training for discussing concerns with a partner (received vs not received); and (4) intimacy promotion skills training (received vs not received). Cores will be fully automated and implemented using a robust internet intervention platform with highly engaging elements such as animation, video, and automated email prompts. Survivors will complete web-based assessments at baseline (prerandomization time point) and again at 12 and 24 weeks later. The primary study aim will be achieved through a decision-making process based on systematically evaluating the main and interaction effects of components on sexual distress (Female Sexual Distress Scale–Desire, Arousal, Orgasm) and sexual functioning (Female Sexual Function Index) using a generalized linear model approach to ANOVA with effect coding. Mediation analyses will be conducted through a structural equation modeling approach, and moderation analyses will be conducted by extending the generalized linear model to include interaction effects. Results: This protocol has been reviewed and approved by the National Cancer Institute Central Institutional Review Board. Data collection is planned to begin in March 2024 and conclude in 2027. Conclusions: By identifying the combination of the fewest and least-intensive intervention components likely to provide survivors of breast cancer the greatest sexual health benefit, this study will result in the first internet intervention that is optimized for maximum impact on the undertreated, prevalent, and distressing problem of breast cancer–related sexual morbidity. Trial Registration: ClinicalTrials.gov NCT06216574; https://clinicaltrials.gov/study/NCT06216574 International Registered Report Identifier (IRRID): PRR1-10.2196/57781

1 January 2021 in International Journal of Medicine in Developing Countries
Verified
Journal Article
Closed access
NTNora Trabulsi
Nora Trabulsi
AAAbdulmajeed Alzahrani
Abdulmajeed Alzahrani
AKAbdulmajeed Khafagy
Abdulmajeed Khafagy
MBMohanned Banaamah
Mohanned Banaamah
FAFawaz Alazdi
Fawaz Alazdi
ASAli Samkari
Ali Samkari

26 February 2024 in JMIR Preprints
Verified
Preprint
Open access
KSKelly M Shaffer
Kelly M Shaffer
JRJennifer Barsky Reese
Jennifer Barsky Reese
EDEmily V Dressler
Emily V Dressler
JGJillian V Glazer
Jillian V Glazer
WCWendy Cohn
Wendy Cohn
LRLee M Ritterband
Lee M Ritterband
BACKGROUND Although most survivors of breast cancer report substantial sexual concerns following treatment, few receive support for these concerns. Delivering sexual health care to survivors of breast cancer via the internet could overcome many of the barriers to in-person treatment. Even when delivered remotely, survivor time constraints remain a leading barrier to sexual health intervention uptake. OBJECTIVE Guided by the multiphase optimization strategy methodological framework, the primary objective of this study is to identify the most efficient internet-delivered sexual health intervention package that is expected to provide survivors of breast cancer the greatest benefit with the fewest (and least-intensive) intervention components. This study aims to determine how intervention components work (mediators) and for whom they work best (moderators). METHODS Partnered, posttreatment adult female survivors of breast cancer (N=320) experiencing at least 1 bothersome sexual symptom (ie, pain with sex, vaginal dryness, low sexual desire, and difficulty with orgasm) related to their breast cancer treatment will be enrolled. Clinic-based recruitment will be conducted via the Wake Forest National Cancer Institute Community Oncology Research Program (NCORP) Research Base. Participants will be randomly assigned to 1 of 16 combinations of four intervention components with two levels each in this factorial trial: (1) psychoeducation about cancer-related sexual morbidity (receive either enhanced vs standard versions); (2) communication skills training for discussing concerns with health care providers (received vs not received); (3) communication skills training for discussing concerns with a partner (received vs not received); and (4) intimacy promotion skills training (received vs not received). Cores will be fully automated and implemented using a robust internet intervention platform with highly engaging elements such as animation, video, and automated email prompts. Survivors will complete web-based assessments at baseline (prerandomization time point) and again at 12 and 24 weeks later. The primary study aim will be achieved through a decision-making process based on systematically evaluating the main and interaction effects of components on sexual distress (Female Sexual Distress Scale–Desire, Arousal, Orgasm) and sexual functioning (Female Sexual Function Index) using a generalized linear model approach to ANOVA with effect coding. Mediation analyses will be conducted through a structural equation modeling approach, and moderation analyses will be conducted by extending the generalized linear model to include interaction effects. RESULTS This protocol has been reviewed and approved by the National Cancer Institute Central Institutional Review Board. Data collection is planned to begin in March 2024 and conclude in 2027. CONCLUSIONS By identifying the combination of the fewest and least-intensive intervention components likely to provide survivors of breast cancer the greatest sexual health benefit, this study will result in the first internet intervention that is optimized for maximum impact on the undertreated, prevalent, and distressing problem of breast cancer–related sexual morbidity. CLINICALTRIAL ClinicalTrials.gov NCT06216574; https://clinicaltrials.gov/study/NCT06216574 INTERNATIONAL REGISTERED REPORT PRR1-10.2196/57781